It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. As more agents are evaluated either in addition to or following PD-1/PD-L1 inhibitors, more information may be learned about how best to leverage alternate biomarkers, according to Marina C. Garassino, MD. Nurses should claim only the credit commensurate with the extent of their participation in the activity. Benjamin Philip Levy, MD, discusses potential methods to optimize molecular testing in lung cancer. ADCs Showcase Impressive Activity, Second-Line Combos Seek to Raise the Bar in Quest to Target HER2+ NSCLC. International Lung Cancer Congress - OncLive Enjoy special rates and added complimentary amenities when you book your accommodation together with your registration! Describe current and evolving management strategies for patients with localized and locally advanced lung cancer. Use tab to navigate through the menu items. View our latest updates. IVBH. ASH Webinar, 2023 What Changes Monday Morning? Overall, the test correctly revealed cancer 66% of the time (Stock image) A blood test that can detect more than 50 different types of cancer has shown promise . This one-day conference will provide a comprehensive, multidisciplinary update on recent clinical advances in lung cancer. This symposium is not certified for continuing education credit. Password must be between 8 and 16 characters and contain the following: For More Details: https://medstar.cloud-cme.com/course/courseoverview?P=0&EID=26337, I am a MedStar Associate (login via SiTEL), Must be between 8 and 16 characters in length, Must Contain at least 1 upper case character, Must Contain at least 1 lower case character, Must contain at least 1 numeric character, Must contain at least 1 of the following ! orating data from the major oncologic annual meetings. We invite you to join us for the 1st Annual Best of Lung Cancer conference. All funding for this site is provided directly by ESMO. Whereas the harmful effects of smoking on health are well recognized, the negative impacts of continued smoking after a diagnosis of cancer are underappreciated. American Board of Internal Medicine MOC Credit. Marks, MDHematologist & Medical Oncologist, Michael E. Menefee, MDAssistant Professor, Medicine, Drew Moghanaki, MD, MPHProfessor of Radiation Oncology, Consulting Fee-Astra Zeneca Astra Zeneca|Advisor-Merck (Relationship has ended), Nitika Paudel, MD, PhDRadiation Oncologist, Radiation Medicine; Assistant Professor, Radiation Medicine, Speakers Bureau-Astra Zeneca Astra Zeneca (Relationship has ended), Zofia Piotrowska, MD, MHSMedical Oncologist, Assistant Professor, Medicine, Joshua E. Reuss, MDThoracic Medical Oncologist; Assistant Professor, Medicine, Membership on Advisory Committees or Review Panels, Board Membership, etc.-Mirati Therapeutics (Relationship has ended). Convention Centre Pl 1. Concurrent chemoradiation followed by durvalumab has become the standard of care for patients with unresectable stage III nonsmall cell lung cancer based on the results of the phase 3 PACIFIC trial. Lyudmila A. Bazhenova, MD, discusses future research questions with fam-trastuzumab deruxtecan-nxki in HER2-mutated lung cancer. Managing lung cancer has gotten increasingly complicated reflecting the transformative benefits we see with immunotherapy and targeted therapy. Free registration for all healthcare providers, Expert video sessions that present the most clinically relevant data, research, and clinical strategies, Enduring video content for watching at your leisure, Virtual networking with peers, colleagues, and medical professionals, Virtual access to the latest industry information and resources, 2023 by Total Health Information Services, LLC. Melbourne Convention and Exhibtion Centre. Join us as we look ahead at lung cancer nursing, exploring ways to ensure the workforce is fit for the future and asking where we go from here. However, several strategies are under clinical evaluation to push the paradigm beyond the PACIFIC regimen. Convened and co-sponsored by Monash BDI, CSTI 2023 is the fifth in the biennial CSTI conference series. Materials are available in English and Spanish. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences. Immunotherapy Must Become More Precise and Personalized in Lung Cancer. Provide a global review of lung cancer screening clinical trials, implementation studies, and organized programs. San Antonio Breast Webinar, Total Health Conferencing brings you the very best in, 2023 Cancer Updates Lung Cancer Dinner Program, 2023 Oncology Nursing Society Metro Denver Chapter Conference, 2023 Spring Oncology Education Retreat Lake Tahoe, 2023 Community Oncology Educational Discussion Series Fort Lauderdale, Diversity, Equity, and Inclusion: Primary Care to OncologyConversations for Change, 2023 University of Kansas Cancer Center Breast Cancer Year in Review. The ESMO Daily Reporter is the official ESMO newspaper providing live reporting, highlights, critical insights on data presented at ESMO congresses, and expert opinions on controversial topics. IASLC 2023 North America Conference on Lung Cancer, JTO Clinical and Research Reports (JTO CRR), IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer, Career Development and Fellowship Committee, Nurses and Allied Health Professionals Committee, Tobacco Control and Smoking Cessation Committee. For inquiries please emails us at TexasLung@IDEOlogyHealth.com. An ineligible company is any entity whose primary business is producing, marketing, Lung Cancer Conference will emphasize current best practices for busy clinicians who care for patients with lung cancer, across disciplines. This map facilitates policy-level discussions drawing from real-world implementation around the world and drives a community of learning around LDCT (Low Dose Computed Tomography) screening. Pharmacists and Pharmacy Technicians (ACPE) Credit Designation. Although PD-L1 expression and histology served as helpful stratification factors in pivotal trials, the paradigm will need to build out more tailored selection strategies as additional checkpoint inhibitors move through development. Durvalumab Delivers Durable Benefit, Regardless of PD-L1 Expression, in NSCLC. Mon, 12 Jun 2023 - Tue, 13 Jun 2023. The Texas Lung Cancer Conference promises to be one of the biggest lung cancer events of the year. Advance Purchase and Onsite Rate August 7 to October 7, Please contact[emailprotected]or (833) 731-1273 for registrationassistance. If you are interested in supporting the program, please contactElizabeth Romanoat[emailprotected]. Home - 2023 Targeted Therapies of Lung Cancer Meeting PER Winter Lung Cancer Conference - OncLive Additionally, the Isabella & Marcus Foundation, a devoted philanthropic organisation spearheading research into paediatric brain cancer, stood as a longstanding partner of CSTI. TEQSA Provider ID: PRV12140, Monash University: 00008CMonash College: 01857J, Chief Marketing OfficerUniversity Marketing, Admissions and Communications, Monash Biomedicine Discovery Institute The field is evolving very rapidly and over the past year, there have been major shifts in our understanding of this highly lethal disease. The Universal Activity Number for this program is UAN# JA4008151-0000-23-030-L05-P. Hotel arrangements can be made online at:book.passkey.com/go/MedstarHealth2023. This innovative and state of the art program will feature some of the world's leading lung cancer experts to present the latest research and strategies for the care of lung cancers incorporating data from the major oncologic annual meetings. Russell Kenneth Hales, MD, discusses investigational treatment strategies that have the potential to build upon the positive results of the phase 3 PACIFIC trial in stage III nonsmall cell lung cancer. Why Attend TTLC 2023? Welcome | Australian Lung Cancer Conference 2023 The NACLC 2023is a dynamic meeting with a long tradition and will feature the most up-to-date research, diverse topics of interest, and educational sessions with leading experts. Describe current standard care for advanced mesothelioma. WCLC 2022 World Conference on Lung Cancer - HealthManagement.org Describe the approved use of tumor treating fields. Kuoni Global Travel Services Congresshas been appointed as official housing agency for the ELCC 2023, ESMO COVID-19 regulations to access the congress, Contact information for the event organisers, Follow #ELCC23 on Facebook, Twitter, LinkedIn, Instagram and YouTube. September 1-4, 2023. These recommendations are intended as guidance for clinical trials, although it is hoped they can be viewed as suggestions for good clinical practice outside of clinical trials, to improve the consistency of pathologic assessment of treatment response. "Not only did we bring together the foremost experts in the field, but we also witnessed a true synergy of ideas and collaborations that will undoubtedly accelerate progress in cancer research," said the co-convenors in a joint statement. In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. Nationwide, only 20.8% of lung cancer cases underwent surgery as the first course of treatment in 2022, according to the American Lung Association.Just 5.8% of eligible Americans have been . The IASLC is a global multidisciplinary organization dedicated to eradication of all forms of lung cancer. Currently, there is no established guidance on how to process and evaluate resected lung cancer specimens following neoadjuvant therapy in the setting of clinical trials and clinical practice. Industry partners: find out how to get involved. Repeat Molecular Testing Is Beneficial in EGFR+ NSCLC With Acquired Resistance. Abstracts and ePosters are open access.Presentations(slides) andwebcasts are available toregistered delegates according to the presenters' agreement to release them. Debate the use of targeted therapy for patients with resected EGFR mutant non-small cell lung cancer. The Texas Lung Cancer Conference is more than a rehash of the available data it is an opportunity to understand the reasoning behind the trials and the best approach to patient care. Showcase your research and contribute to discussions that will shape the future of treatments in lung cancer and thoracic malignancies. The two-day CE event will take place at the historic ACL Live at the Moody Theater in Austin, Texas, known as the Live Music Capital In The World. Integrate a team-based approach in the care of patients with lung cancer. NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. Latest breakthroughs in translational cancer research on show at CSTI In a poignant tribute, the prestigious Lackmann Award was presented by BDI Cancer Program Co-head Professor Roger Daly in honour of the late Professor Martin Lackmann. PD-1 Inhibitor Combinations, Alternative Therapeutic Approaches Are Moving the Needle in NSCLC. including lung cancer evolution and environmental factors (Professor Charles Swanton, Francis Crick Institute), new . Immunotherapy Advances Drive Progress in Lung Cancer Treatment. Welcome | Australian Lung Cancer Conference 2023 Welcome Towards 2030 - a decade of transformation in lung cancer On behalf of the Lung Foundation Australia, we warmly invite to you to be part of the 9th Australian Lung Cancer Conference to be held on the beautiful Gold Coast, Queensland from 15-17 February 2023.
How To Find Import Data Of A Company,
Original Crazy Foam Commercial,
Dance Master Classes In Boston,
Articles L